NYSEAMERICAN:EVO Eaton Vance Ohio Municipal Income Trust (EVO) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free EVO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$7.57▼$7.8050-Day Range N/A52-Week Range$11.74▼$13.11Volume33,841 shsAverage Volume24,684 shsMarket Capitalization$2.76 billionP/E Ratio41.05Dividend YieldN/APrice Target$14.50 Stock AnalysisStock AnalysisAnalyst ForecastsHeadlinesStock AnalysisAnalyst ForecastsHeadlines Get Eaton Vance Ohio Municipal Income Trust alerts: Email Address Eaton Vance Ohio Municipal Income Trust MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside85.9% Upside$14.50 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth520.00%From $0.05 to $0.31 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.29 out of 5 stars 3.3 Analyst's Opinion Consensus RatingEaton Vance Ohio Municipal Income Trust has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEaton Vance Ohio Municipal Income Trust has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for EVO. Previous Next 0.0 Dividend Strength Dividend YieldEaton Vance Ohio Municipal Income Trust does not currently pay a dividend.Dividend GrowthEaton Vance Ohio Municipal Income Trust does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVO. Previous Next 0.6 News and Social Media Coverage Search Interest2 people have searched for EVO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Eaton Vance Ohio Municipal Income Trust insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.39% of the stock of Eaton Vance Ohio Municipal Income Trust is held by institutions. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Eaton Vance Ohio Municipal Income Trust are expected to grow by 520.00% in the coming year, from $0.05 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Eaton Vance Ohio Municipal Income Trust is 41.05, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 148.68.Price to Earnings Ratio vs. SectorThe P/E ratio of Eaton Vance Ohio Municipal Income Trust is 41.05, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 267.25.Price to Book Value per Share RatioEaton Vance Ohio Municipal Income Trust has a P/B Ratio of 2.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. About Eaton Vance Ohio Municipal Income Trust Stock (NYSEAMERICAN:EVO)Eaton Vance Ohio Municipal Income Trust is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. It invests in the fixed income markets. The fund invests primarily in debt securities issued by cogeneration, education, electric utilities, general obligations, hospital, industrial development, transportation, and water and sewer sectors. Eaton Vance Ohio Municipal Income Trust was formed in 1998 and is domiciled in United States.Read More Ad Insider FinancialThousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" EVO Stock News HeadlinesApril 17, 2024 | finance.yahoo.comEvotec welcomes Aurélie Dalbiez as Chief People OfficerMarch 18, 2024 | finance.yahoo.comEvotec (ETR:EVT shareholders incur further losses as stock declines 3.7% this week, taking three-year losses to 59%April 24, 2024 | Insider Financial (Ad)Thousands of investors use this no cost solution | Do you? In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.January 10, 2024 | finance.yahoo.comEvotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD TherapiesDecember 6, 2023 | finance.yahoo.comEvotec-partner Jingxin Receives Approval for EVT201 in ChinaDecember 4, 2023 | finance.yahoo.comEvotec SE's (ETR:EVT) largest shareholders are individual investors with 47% ownership, institutions own 34%November 15, 2023 | finance.yahoo.comEvotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets DayNovember 7, 2023 | finance.yahoo.comDewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology PipelineApril 24, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… November 7, 2023 | finance.yahoo.comEvotec and Dewpoint Therapeutics Enter Strategic Partnership in OncologyAugust 29, 2023 | finance.yahoo.comEvotec SE Reports Results for the First Half-year 2023 and Provides Corporate UpdatesAugust 24, 2023 | seekingalpha.comETX Eaton Vance Municipal Income 2028 Term TrustAugust 22, 2023 | finance.yahoo.comEvotec SE Reports First Half-Year 2023 Results on 29 August 2023July 28, 2023 | finance.yahoo.comEvotec Provides Update on Financial Impact of Cyber-AttackJuly 11, 2023 | finance.yahoo.comEvotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience PartnershipJuly 5, 2023 | finance.yahoo.comJust - Evotec Biologics Awarded Second Contract from U.S. Department of Defense Under Accelerated Antibodies ProgramJune 29, 2023 | finance.yahoo.comEvotec Receives Milestone Payment for First Patient Dosed in Phase I Study of Bayer Kidney Disease ProgrammeJune 8, 2023 | finance.yahoo.comUPDATE 1-European shares dip on rate jitters, banks riseJune 5, 2023 | finance.yahoo.comEvotec Presents Sustainability StrategyMay 12, 2023 | finance.yahoo.comEvotec publishes Annual Report 2022 and Quarterly Statement for Q1 2023May 9, 2023 | finance.yahoo.comJust - Evotec Biologics Enters Strategic Biosimilars Partnership with SandozApril 24, 2023 | finance.yahoo.comSuccessful Results Using Sernova’s Cell Pouch System™ with Evotec’s iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF SummitApril 17, 2023 | finance.yahoo.comEvotec (ETR:EVT) pulls back 5.0% this week, but still delivers shareholders notable 6.1% CAGR over 5 yearsApril 7, 2023 | finance.yahoo.comCyber Attack on EvotecMarch 21, 2023 | finance.yahoo.comEvotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023February 10, 2023 | finance.yahoo.comEvotec Receives € 150 m Loan from European Investment BankJanuary 26, 2023 | finance.yahoo.comEvotec Announces Agreement with Janssen to Develop Immune-Based TherapiesSee More Headlines Receive EVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eaton Vance Ohio Municipal Income Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNYSEAMERICAN:EVO Previous SymbolNYSEMKT:EVO CUSIPN/A CIKN/A Webfunds.eatonvance.com Phone+1-617-4828260Fax49-40-5608-1222Employees4,952Year FoundedN/APrice Target and Rating Average Stock Price Target$14.50 High Stock Price Target$16.00 Low Stock Price Target$13.00 Potential Upside/Downside+85.9%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)$0.19 Trailing P/E Ratio41.05 Forward P/E Ratio156.00 P/E GrowthN/ANet Income$-185,070,000.00 Net Margins-23.38% Pretax Margin-20.49% Return on Equity-13.93% Return on Assets-7.75% Debt Debt-to-Equity Ratio0.41 Current Ratio3.18 Quick Ratio3.09 Sales & Book Value Annual Sales$791.73 million Price / Sales3.49 Cash FlowN/A Price / Cash FlowN/A Book Value$3.53 per share Price / Book2.21Miscellaneous Outstanding Shares353,900,000Free FloatN/AMarket Cap$2.76 billion OptionableNot Optionable Beta1.35 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Payson F. Swaffield CFAVP, Chief Income Investment Officer & Portfolio Mang.Mr. Paul M. O'Neil (Age 66)Chief Compliance Officer Ms. Maureen Ann Gemma (Age 59)Chief Legal Officer, VP and Sec. Mr. James F. Kirchner (Age 52)Treasurer Ms. Cynthia J. Clemson (Age 56)Portfolio Mang. Key CompetitorsACADIA PharmaceuticalsNASDAQ:ACADMoonLake ImmunotherapeuticsNASDAQ:MLTXMorphoSysNASDAQ:MORIDEAYA BiosciencesNASDAQ:IDYAJanux TherapeuticsNASDAQ:JANXView All Competitors EVO Stock Analysis - Frequently Asked Questions Should I buy or sell Eaton Vance Ohio Municipal Income Trust stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Eaton Vance Ohio Municipal Income Trust in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVO shares. View EVO analyst ratings or view top-rated stocks. What is Eaton Vance Ohio Municipal Income Trust's stock price target for 2024? 3 Wall Street analysts have issued twelve-month target prices for Eaton Vance Ohio Municipal Income Trust's shares. Their EVO share price targets range from $13.00 to $16.00. On average, they expect the company's share price to reach $14.50 in the next year. This suggests a possible upside of 85.9% from the stock's current price. View analysts price targets for EVO or view top-rated stocks among Wall Street analysts. What other stocks do shareholders of Eaton Vance Ohio Municipal Income Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other Eaton Vance Ohio Municipal Income Trust investors own include Abeona Therapeutics (ABEO), AGNC Investment (AGNC), Enterprise Products Partners (EPD), Franklin Universal Trust (FT), (VNGBQ) (VNGBQ), (VNRSQ) (VNRSQ), Atlas Air Worldwide (AAWW), Ariana Resources (AAU), Atlantic Alliance Partnership (AAPCF) and AAON (AAON). This page (NYSEAMERICAN:EVO) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eaton Vance Ohio Municipal Income Trust Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
